[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Drops 10% Over Last Week Despite Dupixent Approval in Japan",
    "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) saw its share price decline by 10% over the past week. The recent approval of Dupixent for COPD in Japan was expected to bolster investor confidence, yet the broader market's turmoil overshadowed this positive news. Nearly all major indices, including the Nasdaq, faced substantial losses as escalating trade tensions led to fears of a slowing economy. With the Nasdaq entering bear market territory, many companies in the healthcare sector, including...",
    "url": "https://finnhub.io/api/news?id=2523a1206aa83a4bcf858e945a57d53d8b5d126593ded86a68fdbb590e16e8c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743874343,
      "headline": "Regeneron Pharmaceuticals (NasdaqGS:REGN) Drops 10% Over Last Week Despite Dupixent Approval in Japan",
      "id": 133727522,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) saw its share price decline by 10% over the past week. The recent approval of Dupixent for COPD in Japan was expected to bolster investor confidence, yet the broader market's turmoil overshadowed this positive news. Nearly all major indices, including the Nasdaq, faced substantial losses as escalating trade tensions led to fears of a slowing economy. With the Nasdaq entering bear market territory, many companies in the healthcare sector, including...",
      "url": "https://finnhub.io/api/news?id=2523a1206aa83a4bcf858e945a57d53d8b5d126593ded86a68fdbb590e16e8c0"
    }
  },
  {
    "ts": null,
    "headline": "3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years",
    "summary": "Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (NASDAQ: BKNG), Apple (NASDAQ: AAPL), and Regeneron Pharmaceuticals (NASDAQ: REGN).  Over the past two decades, Booking Holdings has experienced significant growth as demand for its online booking services has skyrocketed.  Booking.com, Kayak.com, and Priceline.com are some of the names travelers first go to when looking to book a trip -- and Booking Holdings owns all those brands.",
    "url": "https://finnhub.io/api/news?id=7554c130f18534fe1088066131ff3cc05811bd6133ab625374894e2b6a1460d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743837780,
      "headline": "3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years",
      "id": 133727120,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (NASDAQ: BKNG), Apple (NASDAQ: AAPL), and Regeneron Pharmaceuticals (NASDAQ: REGN).  Over the past two decades, Booking Holdings has experienced significant growth as demand for its online booking services has skyrocketed.  Booking.com, Kayak.com, and Priceline.com are some of the names travelers first go to when looking to book a trip -- and Booking Holdings owns all those brands.",
      "url": "https://finnhub.io/api/news?id=7554c130f18534fe1088066131ff3cc05811bd6133ab625374894e2b6a1460d5"
    }
  }
]